{"id":"agn-199201","safety":{"commonSideEffects":[{"rate":null,"effect":"Testosterone suppression"},{"rate":null,"effect":"Liver enzyme elevation"},{"rate":null,"effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"SARMs like AGN-199201 bind to androgen receptors with tissue selectivity, promoting anabolic effects in muscle and bone while minimizing androgenic side effects seen with traditional androgens. This selective activation aims to provide therapeutic benefits for conditions requiring androgen activity without the full systemic effects of conventional hormone replacement.","oneSentence":"AGN-199201 is a selective androgen receptor modulator (SARM) that activates androgen signaling in target tissues.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:00:19.714Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Muscle wasting and weakness in aging males"},{"name":"Osteoporosis or bone loss"}]},"trialDetails":[{"nctId":"NCT02595528","phase":"PHASE2","title":"A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia","status":"COMPLETED","sponsor":"Allergan","startDate":"2016-04-29","conditions":"Presbyopia","enrollment":163},{"nctId":"NCT02780115","phase":"PHASE2","title":"A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia","status":"COMPLETED","sponsor":"Allergan","startDate":"2016-05-26","conditions":"Presbyopia","enrollment":151},{"nctId":"NCT02132117","phase":"PHASE3","title":"Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-06","conditions":"Erythema, Rosacea","enrollment":445},{"nctId":"NCT02131636","phase":"PHASE3","title":"Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-05","conditions":"Erythema, Rosacea","enrollment":440},{"nctId":"NCT02095158","phase":"PHASE3","title":"A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-04","conditions":"Erythema, Rosacea","enrollment":440},{"nctId":"NCT01579084","phase":"PHASE1","title":"Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea","status":"COMPLETED","sponsor":"Allergan","startDate":"2012-04","conditions":"Rosacea, Erythema","enrollment":64},{"nctId":"NCT01735201","phase":"PHASE2","title":"AGN-199201 for the Treatment of Erythema With Rosacea","status":"COMPLETED","sponsor":"Allergan","startDate":"2012-12","conditions":"Rosacea, Erythema","enrollment":357},{"nctId":"NCT02197806","phase":"PHASE2","title":"Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-07","conditions":"Presbyopia","enrollment":65}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AGN-199201","genericName":"AGN-199201","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AGN-199201 is a selective androgen receptor modulator (SARM) that activates androgen signaling in target tissues. Used for Muscle wasting and weakness in aging males, Osteoporosis or bone loss.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}